195 related articles for article (PubMed ID: 1982756)
1. Mode of action of beta-adrenergic blocking drugs in hypertension.
Prichard BN; Owens CW
Clin Physiol Biochem; 1990; 8 Suppl 2():1-10. PubMed ID: 1982756
[TBL] [Abstract][Full Text] [Related]
2. Haemodynamic consequences of intrinsic sympathomimetic activity in relation to changes in plasma renin activity and noradrenaline during beta-blocker therapy for hypertension.
Man in't Veld AJ; Schalekamp MA
Postgrad Med J; 1983; 59 Suppl 3(689):140-58. PubMed ID: 6139800
[TBL] [Abstract][Full Text] [Related]
3. Antihypertensive effects of 12 beta adrenoceptor antagonists in conscious spontaneously hypertensive rats: relationship to changes in plasma renin activity, heart rate and sympathetic nerve function.
Antonaccio MJ; High J; DeForrest JM; Sybertz E
J Pharmacol Exp Ther; 1986 Jul; 238(1):378-87. PubMed ID: 2873238
[TBL] [Abstract][Full Text] [Related]
4. [Pharmacological basis for the therapy of cardiovascular disease with beta-adrenoceptor blocking drugs (author's transl)].
Lemmer B
Herz; 1982 Jun; 7(3):168-78. PubMed ID: 6124492
[TBL] [Abstract][Full Text] [Related]
5. Antihypertensive action of beta-adrenoceptor blockade and the renin-angiotensin system.
Gavras I; Gavras H; Brunner HR; Liang CS
Br J Clin Pharmacol; 1979; 7 Suppl 2(Suppl 2):213S-217S. PubMed ID: 37876
[TBL] [Abstract][Full Text] [Related]
6. Beta-blockers in the treatment of hypertension: are there clinically relevant differences?
Weir MR
Postgrad Med; 2009 May; 121(3):90-8. PubMed ID: 19491545
[TBL] [Abstract][Full Text] [Related]
7. Central hemodynamics of beta-adrenoceptor blocking drugs: beta 1 selectivity versus intrinsic sympathomimetic activity.
Svendsen TL
J Cardiovasc Pharmacol; 1983; 5 Suppl 1():S21-5. PubMed ID: 6188916
[TBL] [Abstract][Full Text] [Related]
8. Beta-blocking agents with vasodilator activity.
Rosendorff C
J Hypertens Suppl; 1993 Jun; 11(4):S37-40. PubMed ID: 8104240
[TBL] [Abstract][Full Text] [Related]
9. Beta blockers in hypertension: a review.
Kelly KL
Am J Hosp Pharm; 1976 Dec; 33(12):1284-90. PubMed ID: 11687
[TBL] [Abstract][Full Text] [Related]
10. The significance of beta1-beta2-selectivity and intrinsic sympathomimetic activity in beta-blockers, with particular reference to antihypertensive treatment.
Imhof P
Adv Clin Pharmacol; 1976; 11():26-32. PubMed ID: 25568
[TBL] [Abstract][Full Text] [Related]
11. Comparison of beta-blockade and ACE inhibitors in the treatment of hypertension.
Prichard BN; Saul PA
J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S81-5. PubMed ID: 11527141
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular effects of noise.
Andrén L
Acta Med Scand Suppl; 1982; 657():1-45. PubMed ID: 6124083
[TBL] [Abstract][Full Text] [Related]
13. Discordant effects of beta-blockade on central aortic systolic and brachial systolic blood pressure: considerations beyond the cuff.
Epstein BJ; Anderson S
Pharmacotherapy; 2007 Sep; 27(9):1322-33. PubMed ID: 17723086
[TBL] [Abstract][Full Text] [Related]
14. [Therapy of hypertension. I. new antihypertensive agents, pharmacologic and pharmacokinetic bases. Beta-adrenergic blockers and blood pressure lowering].
Brunner H
Verh Dtsch Ges Kreislaufforsch; 1977; 43():75-86. PubMed ID: 26152
[No Abstract] [Full Text] [Related]
15. [Effect of nitrates, nitrate-like substances, calcium antagonists and beta-adrenergic receptor blockers on peripheral circulation].
Busse R; Bassenge E
Herz; 1982 Dec; 7(6):388-405. PubMed ID: 6131027
[TBL] [Abstract][Full Text] [Related]
16. Beta adrenoceptor blocking drugs in hypertension.
Turner P
Clin Invest Med; 1978; 1(3-4):129-33. PubMed ID: 42502
[No Abstract] [Full Text] [Related]
17. Are we misunderstanding beta-blockers.
Cruickshank JM
Int J Cardiol; 2007 Aug; 120(1):10-27. PubMed ID: 17433471
[TBL] [Abstract][Full Text] [Related]
18. The second Lilly Prize Lecture, University of Newcastle, July 1977. beta-Adrenergic receptor blockade in hypertension, past, present and future.
Prichard BN
Br J Clin Pharmacol; 1978 May; 5(5):379-99. PubMed ID: 26370
[TBL] [Abstract][Full Text] [Related]
19. Beta-adrenergic blocking agents in the treatment of hypertension. Choices based on pharmacological properties and patient characteristics.
Wallin JD; Shah SV
Arch Intern Med; 1987 Apr; 147(4):654-9. PubMed ID: 2881524
[TBL] [Abstract][Full Text] [Related]
20. Calcium antagonism: aldosterone and vascular responses to catecholamines and angiotensin II in man.
Elliott HL
J Hypertens Suppl; 1993 Dec; 11(6):S13-6. PubMed ID: 8169376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
